Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of VCL mRNA | affects expression | 21346803
|
C024709 |
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone |
2,6-di-tert-butyl-4-methylene-2,5-cyclohexadienone binds to VCL protein | affects binding | 16533022
|
C009505 |
4,4'-diaminodiphenylmethane |
4,4'-diaminodiphenylmethane results in decreased expression of VCL mRNA | decreases expression | 18648102
|
D000643 |
Ammonium Chloride |
Ammonium Chloride results in decreased expression of VCL protein | decreases expression | 16483693
|
D000968 |
Antimycin A |
Antimycin A results in decreased expression of VCL protein | decreases expression | 12490576
|
D000968 |
Antimycin A |
PD 150606 inhibits the reaction [Antimycin A results in decreased expression of VCL protein] | decreases expression|decreases reaction | 12490576
|
D001149 |
Arsenates |
[Atrazine co-treated with Arsenates] results in increased expression of VCL mRNA | affects cotreatment|increases expression | 18585445
|
D001241 |
Aspirin |
Aspirin results in decreased expression of VCL mRNA | decreases expression | 11906190
|
D001280 |
Atrazine |
[Atrazine co-treated with Arsenates] results in increased expression of VCL mRNA | affects cotreatment|increases expression | 18585445
|
D015123 |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide results in decreased expression of VCL mRNA | decreases expression | 19150397
|
D004041 |
Dietary Fats |
Dietary Fats results in decreased expression of VCL mRNA | decreases expression | 18042831
|
D005472 |
Fluorouracil |
VCL protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
C056933 |
fumonisin B1 |
fumonisin B1 results in increased expression of VCL mRNA | increases expression | 16221962
|
D015741 |
Metribolone |
Metribolone results in increased expression of VCL protein | increases expression | 17152098
|
D010100 |
Oxygen |
Oxygen deficiency results in increased expression of VCL mRNA | increases expression | 17914565
|
C041786 |
palm oil |
palm oil results in decreased expression of VCL mRNA | decreases expression | 18042831
|
C100442 |
PD 150606 |
PD 150606 inhibits the reaction [Antimycin A results in decreased expression of VCL protein] | decreases expression|decreases reaction | 12490576
|
C006253 |
pirinixic acid |
[pirinixic acid binds to and results in increased activity of PPARA protein] which results in decreased expression of VCL mRNA | affects binding|decreases expression|increases activity | 19710929
|
C006253 |
pirinixic acid |
pirinixic acid results in increased expression of VCL mRNA | increases expression | 18301758 16221962
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of VCL mRNA | decreases expression | 20308225
|
D013749 |
Tetrachlorodibenzodioxin |
Tetrachlorodibenzodioxin results in increased expression of VCL mRNA | increases expression | 15667827
|
D014212 |
Tretinoin |
Tretinoin results in increased expression of VCL mRNA | increases expression | 16236135
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of VCL mRNA | increases expression | 15345369
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Tetrachlorodibenzodioxin |
7.95 | 11752688 14514962 15322242 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
7.95 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
3.83 | 19490988 |
MESH:D000138 |
Acidosis |
|
Ammonium Chloride |
3.45 | 18287403 |
MESH:D055371 |
Acute Lung Injury |
|
Oxygen |
8.88 | 16759491 |
MESH:D055371 |
Acute Lung Injury |
|
pirinixic acid |
8.88 | 18653653 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
2.40 | 17638652 |
MESH:D000236 |
Adenoma |
|
4,4'-diaminodiphenylmethane |
2.69 | 3712494 |
MESH:D018248 |
Adenoma, Liver Cell |
|
pirinixic acid |
9.54 | 16434500 |
MESH:D018248 |
Adenoma, Liver Cell |
|
Tetrachlorodibenzodioxin |
9.54 | 16835633 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
4.59 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.80 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Atrazine |
4.12 | 11874814 |
MESH:D000505 |
Alopecia |
|
Tretinoin |
3.53 | 15955085 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.13 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
8.35 | 15504547 17963324 16511603 |
MESH:D000740 |
Anemia |
|
Tetrachlorodibenzodioxin |
8.35 | 11748828 |
MESH:D000860 |
Anoxia |
|
Oxygen |
4.95 | 20872349 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.48 | 17497229 |
MESH:D001161 |
Arteriosclerosis |
|
Dietary Fats |
3.78 | 15238619 |
MESH:D001169 |
Arthritis, Experimental |
|
Tretinoin |
3.01 | 16412693 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Tretinoin |
2.24 | 16292516 |
MESH:D001249 |
Asthma |
|
Tretinoin |
2.31 | 16456186 |
MESH:D055963 |
Asthma, Aspirin-Induced |
|
Aspirin |
4.60 | 20485159 12372130 |
MESH:D050197 |
Atherosclerosis |
|
Oxygen |
3.74 | 16391483 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
2.01 | 15238991 17157402 20603192 17507914 18558336 18396377 18985861 18177632 19460635 18940202 19232924 18316065 17688650 16609825 18775368 |
MESH:D001471 |
Barrett Esophagus |
|
Tretinoin |
4.29 | 16935849 |
MESH:D001660 |
Biliary Tract Diseases |
|
4,4'-diaminodiphenylmethane |
4.91 | 1440618 11289319 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.02 | 20046352 17594078 |
MESH:D001778 |
Blood Coagulation Disorders |
|
pirinixic acid |
14.68 | 19483382 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tetrachlorodibenzodioxin |
14.68 | 12125929 |
MESH:D001778 |
Blood Coagulation Disorders |
|
Tretinoin |
14.68 | 16206674 16197459 |
MESH:D001836 |
Body Weight Changes |
|
Tetrachlorodibenzodioxin |
3.69 | 15340226 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Tetrachlorodibenzodioxin |
7.79 | 15746008 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
7.79 | 8888407 |
MESH:D001932 |
Brain Neoplasms |
|
Aspirin |
4.32 | 15481559 |
MESH:D001943 |
Breast Neoplasms |
|
Aspirin |
2.92 | 15161893 |
MESH:D001943 |
Breast Neoplasms |
|
Dietary Fats |
2.92 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.92 | 18357371 16557594 16110121 19217205 16595493 15136595 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Oxygen |
2.92 | 17263869 |
MESH:D001943 |
Breast Neoplasms |
|
Tetrachlorodibenzodioxin |
2.92 | 20435547 |
MESH:D001943 |
Breast Neoplasms |
|
Tretinoin |
2.92 | 16166294 16873071 16443354 |
MESH:D001997 |
Bronchopulmonary Dysplasia |
|
Tretinoin |
4.48 | 16813970 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.56 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
7.89 | 17121937 |
MESH:D002277 |
Carcinoma |
|
Tetrachlorodibenzodioxin |
7.89 | 16835633 |
MESH:D018236 |
Carcinoma, Embryonal |
|
Tretinoin |
5.05 | 16168501 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
8.69 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
4,4'-diaminodiphenylmethane |
8.69 | 3581430 7296757 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
8.69 | 16799960 17045692 17971768 16332177 17088986 18930000 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
8.69 | 17306315 15276417 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Tretinoin |
8.69 | 1917145 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
4,4'-diaminodiphenylmethane |
6.33 | 7296757 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
6.33 | 18695887 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
7.38 | 18986760 16757204 17066447 16280240 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
7.38 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tretinoin |
7.38 | 16051514 16096774 |
MESH:D006332 |
Cardiomegaly |
|
Tetrachlorodibenzodioxin |
2.31 | 18850075 18670907 16120746 |
MESH:D002311 |
Cardiomyopathy, Dilated |
marker/mechanism |
|
| |
OMIM:613255 |
CARDIOMYOPATHY, FAMILIAL HYPERTROPHIC, 15 |
marker/mechanism |
|
| |
MESH:D002386 |
Cataract |
|
Tretinoin |
3.03 | 17460283 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
15.40 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
4,4'-diaminodiphenylmethane |
15.40 | 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
15.40 | 20889678 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
15.40 | 20056578 19524636 |
MESH:D018290 |
Cervical Intraepithelial Neoplasia |
|
Tretinoin |
4.48 | 16129372 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.67 | 20734317 |
MESH:D018281 |
Cholangiocarcinoma |
|
Tetrachlorodibenzodioxin |
3.07 | 16835633 |
MESH:D002779 |
Cholestasis |
|
4,4'-diaminodiphenylmethane |
7.57 | 9022650 19486331 |
MESH:D002779 |
Cholestasis |
|
pirinixic acid |
7.57 | 19176532 |
MESH:D002822 |
Choriocarcinoma |
|
Tretinoin |
5.05 | 16461808 |
MESH:D002972 |
Cleft Palate |
|
Tetrachlorodibenzodioxin |
5.61 | 15340226 8697196 12621046 16354765 15668235 |
MESH:D002972 |
Cleft Palate |
|
Tretinoin |
5.61 | 9407595 |
MESH:D003092 |
Colitis |
|
Tretinoin |
3.60 | 17035595 |
MESH:D003110 |
Colonic Neoplasms |
|
Aspirin |
4.04 | 12411196 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
4.04 | 17018589 17287894 18772588 17172411 16340194 17725105 16510598 15001691 17016597 17169374 |
MESH:D015179 |
Colorectal Neoplasms |
|
Aspirin |
2.85 | 17047198 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.85 | 20501625 17094418 16391804 18383874 18448328 18949393 18802399 17016601 16282729 17594712 18509181 18288408 15289873 16524972 17695437 17454858 16303861 15148649 17255274 16331619 14970324 17401013 |
MESH:D000013 |
Congenital Abnormalities |
|
Tetrachlorodibenzodioxin |
2.96 | 14669216 17141729 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tetrachlorodibenzodioxin |
3.69 | 15322242 20055451 10048152 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Tretinoin |
3.69 | 9224671 9125849 17551590 14991402 9211117 8800419 10589399 9664655 9142499 16925845 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
3.69 | 17688650 16575769 8888407 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
3.91 | 18551238 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.68 | 16733453 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
4,4'-diaminodiphenylmethane |
2.70 | 18759878 11298694 8970840 14531868 12868966 8156756 11906362 2524372 |
MESH:D003876 |
Dermatitis, Atopic |
|
pirinixic acid |
2.38 | 18249437 |
MESH:D003877 |
Dermatitis, Contact |
|
4,4'-diaminodiphenylmethane |
3.39 | 3621924 2952479 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Tetrachlorodibenzodioxin |
1.64 | 17107852 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
11.68 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
4,4'-diaminodiphenylmethane |
11.68 | 6482804 6679447 18692083 9328219 18289764 7440962 9022650 16192314 18648102 1440618 11289319 9653073 8291058 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
fumonisin B1 |
11.68 | 16221962 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Tetrachlorodibenzodioxin |
11.68 | 20420201 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
11.68 | 19641884 1733752 |
MESH:D004362 |
Drug Toxicity |
|
Tetrachlorodibenzodioxin |
2.68 | 11462148 |
MESH:D050171 |
Dyslipidemias |
|
Dietary Fats |
3.37 | 18367378 |
MESH:D004417 |
Dyspnea |
|
Oxygen |
4.73 | 20016425 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
3.94 | 1851702 |
MESH:D004487 |
Edema |
|
Aspirin |
10.92 | 17259670 |
MESH:D004487 |
Edema |
|
pirinixic acid |
10.92 | 12083418 |
MESH:D004487 |
Edema |
|
Tetrachlorodibenzodioxin |
10.92 | 11000095 12711302 |
MESH:D004489 |
Edema, Cardiac |
|
Tetrachlorodibenzodioxin |
11.59 | 15322242 18230668 16714409 |
MESH:D004489 |
Edema, Cardiac |
|
Tretinoin |
11.59 | 18230668 |
MESH:D016889 |
Endometrial Neoplasms |
|
Tretinoin |
3.04 | 16569247 |
MESH:D004715 |
Endometriosis |
|
Tetrachlorodibenzodioxin |
2.92 | 10568697 9294722 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.04 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
3.81 | 3922381 16628512 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
2.88 | 20417680 18234410 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.49 | 6426943 7562514 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.19 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
3.96 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
4,4'-diaminodiphenylmethane |
7.08 | 3581430 |
MESH:D004938 |
Esophageal Neoplasms |
|
7,8-Dihydro-7,8-dihydroxybenzo(a)pyrene 9,10-oxide |
7.08 | 20426865 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
7.08 | 16337965 17638652 16481741 15173087 16785472 |
MESH:D005124 |
Eye Abnormalities |
|
Tetrachlorodibenzodioxin |
8.56 | 11564622 |
MESH:D005124 |
Eye Abnormalities |
|
Tretinoin |
8.56 | 16938888 9664655 |
MESH:D005234 |
Fatty Liver |
|
Dietary Fats |
12.53 | 18296743 17967931 19551842 19004024 |
MESH:D005234 |
Fatty Liver |
|
pirinixic acid |
12.53 | 20131406 19236843 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
12.53 | 19224547 14986274 |
MESH:D005313 |
Fetal Death |
|
Tetrachlorodibenzodioxin |
3.35 | 11858732 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
4.78 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.02 | 8888407 18558336 |
MESH:D005350 |
Fibroma |
|
4,4'-diaminodiphenylmethane |
4.91 | 6705139 |
MESH:D005355 |
Fibrosis |
|
Dietary Fats |
14.14 | 18296743 |
MESH:D005355 |
Fibrosis |
|
Tetrachlorodibenzodioxin |
14.14 | 20067830 |
MESH:D005355 |
Fibrosis |
|
Tretinoin |
14.14 | 17994277 |
MESH:D005739 |
Gas Poisoning |
|
Oxygen |
5.11 | 20016425 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
4.57 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Aspirin |
7.23 | 12870263 |
MESH:D005909 |
Glioblastoma |
|
Tretinoin |
7.23 | 17312396 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
2.83 | 16145905 |
MESH:D006042 |
Goiter |
|
4,4'-diaminodiphenylmethane |
3.93 | 7505956 |
MESH:D006058 |
Gonadal Disorders |
|
Tetrachlorodibenzodioxin |
4.49 | 10696789 |
MESH:D006261 |
Headache |
|
Aspirin |
4.85 | 15240983 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
7.55 | 18337622 15102660 15162350 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Tretinoin |
7.55 | 16096774 |
MESH:D006317 |
Hearing Loss, Noise-Induced |
|
Tretinoin |
5.05 | 16084493 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tetrachlorodibenzodioxin |
6.34 | 10048152 11294989 |
MESH:D006330 |
Heart Defects, Congenital |
|
Tretinoin |
6.34 | 14991402 9664655 |
MESH:D006333 |
Heart Failure |
|
pirinixic acid |
2.47 | 20558911 |
MESH:D006470 |
Hemorrhage |
|
Tetrachlorodibenzodioxin |
3.23 | 11000095 |
MESH:D006505 |
Hepatitis |
|
4,4'-diaminodiphenylmethane |
3.41 | 6705139 |
MESH:D006529 |
Hepatomegaly |
|
fumonisin B1 |
13.86 | 16221962 |
MESH:D006529 |
Hepatomegaly |
|
pirinixic acid |
13.86 | 19772884 19176532 16221962 18467677 |
MESH:D006529 |
Hepatomegaly |
|
Tetrachlorodibenzodioxin |
13.86 | 16120746 12621046 15340226 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
3.06 | 12676792 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
4.76 | 17688650 |
MESH:D006869 |
Hydronephrosis |
|
Tetrachlorodibenzodioxin |
3.94 | 15340226 8697196 18606429 16959395 16354765 |
MESH:D012001 |
Hyperacusis |
|
Aspirin |
5.66 | 15240983 |
MESH:D006930 |
Hyperalgesia |
|
Tretinoin |
3.12 | 16870215 |
MESH:D006937 |
Hypercholesterolemia |
|
Dietary Fats |
3.49 | 21332399 |
MESH:D017681 |
Hypereosinophilic Syndrome |
|
Tretinoin |
4.46 | 16778211 |
MESH:D006943 |
Hyperglycemia |
|
pirinixic acid |
3.08 | 20558911 |
MESH:D006949 |
Hyperlipidemias |
|
Dietary Fats |
3.51 | 21332399 |
MESH:D006965 |
Hyperplasia |
|
4,4'-diaminodiphenylmethane |
3.83 | 15034207 |
MESH:D006973 |
Hypertension |
|
Tetrachlorodibenzodioxin |
1.87 | 18850075 18670907 |
MESH:D007248 |
Infertility, Male |
|
Atrazine |
6.85 | 12948887 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
6.85 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Dietary Fats |
4.73 | 20412841 |
MESH:D007249 |
Inflammation |
|
Tetrachlorodibenzodioxin |
4.73 | 12200463 12878042 |
MESH:D007333 |
Insulin Resistance |
|
Dietary Fats |
7.01 | 18457598 11836018 |
MESH:D007333 |
Insulin Resistance |
|
pirinixic acid |
7.01 | 16306350 |
MESH:D007410 |
Intestinal Diseases |
|
Tretinoin |
3.66 | 17994277 |
MESH:D007565 |
Jaundice |
|
4,4'-diaminodiphenylmethane |
4.91 | 9022650 8074119 |
MESH:D007569 |
Jaw Abnormalities |
|
Tetrachlorodibenzodioxin |
9.59 | 16580747 |
MESH:D007569 |
Jaw Abnormalities |
|
Tretinoin |
9.59 | 17551590 15992940 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
2.74 | 20008137 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
11.91 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
4,4'-diaminodiphenylmethane |
11.91 | 6582329 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
11.91 | 16985049 |
MESH:D007938 |
Leukemia |
|
Tretinoin |
2.72 | 17143497 |
MESH:D007951 |
Leukemia, Myeloid |
|
Tretinoin |
3.60 | 19285840 16932348 16482212 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Tretinoin |
3.82 | 16294345 19850784 17596541 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
3.82 | 16294345 17596541 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
Tretinoin |
3.08 | 17506722 16331271 17294898 17649720 16891316 15748426 19029980 16140955 19225113 17368321 12679006 19035177 16823087 17107899 16788101 19642359 17361223 17339181 19075265 17301526 9834237 16935935 16766008 17712046 17217047 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Tretinoin |
3.23 | 9224671 |
MESH:D008103 |
Liver Cirrhosis |
|
Dietary Fats |
2.82 | 18296743 |
MESH:D008105 |
Liver Cirrhosis, Biliary |
|
4,4'-diaminodiphenylmethane |
3.13 | 15034207 9327722 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
pirinixic acid |
3.32 | 15474484 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tetrachlorodibenzodioxin |
3.32 | 12878042 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Tretinoin |
3.32 | 16248980 18397230 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
13.79 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
13.79 | 17045692 15113037 16603448 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
pirinixic acid |
13.79 | 20007298 16377806 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
13.79 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Tetrachlorodibenzodioxin |
13.79 | 16984957 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
9.37 | 2876784 2876786 6135515 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
4,4'-diaminodiphenylmethane |
9.37 | 598648 3712494 1399818 6587162 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Tetrachlorodibenzodioxin |
9.37 | 12151625 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
3.10 | 19095001 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
4.16 | 17228818 |
MESH:D055370 |
Lung Injury |
|
Oxygen |
4.40 | 18339021 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
3.35 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
3.35 | 19931552 17306315 15276417 17077188 16712894 |
MESH:D008175 |
Lung Neoplasms |
|
Tetrachlorodibenzodioxin |
3.35 | 11884234 19555203 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.68 | 15086387 |
MESH:D008527 |
Medulloblastoma |
|
Tretinoin |
2.74 | 17453147 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
3.28 | 19082730 16487513 |
MESH:D008545 |
Melanoma |
|
Tretinoin |
3.28 | 16752155 |
MESH:D008591 |
Meningomyelocele |
|
Tretinoin |
4.32 | 16940565 |
MESH:D008654 |
Mesothelioma |
|
Atrazine |
3.48 | 1916698 |
MESH:D008881 |
Migraine Disorders |
|
Aspirin |
7.60 | 15240983 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
7.60 | 18803445 18765137 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.55 | 16757204 18986760 |
MESH:D009135 |
Muscular Diseases |
|
pirinixic acid |
3.40 | 16239165 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
3.92 | 8888407 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Tretinoin |
7.19 | 17596541 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.19 | 17596541 |
MESH:D009203 |
Myocardial Infarction |
|
Aspirin |
5.78 | 12692751 |
MESH:D009203 |
Myocardial Infarction |
|
pirinixic acid |
5.78 | 19151258 |
MESH:D017202 |
Myocardial Ischemia |
|
Tetrachlorodibenzodioxin |
2.93 | 12213967 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
pirinixic acid |
2.86 | 16411023 |
MESH:D009325 |
Nausea |
|
Aspirin |
5.11 | 15240983 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
3.75 | 18551238 7678174 |
MESH:D009362 |
Neoplasm Metastasis |
|
4,4'-diaminodiphenylmethane |
2.43 | 3581430 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
11.42 | 18600527 16928823 18239605 |
MESH:D009369 |
Neoplasms |
|
pirinixic acid |
11.42 | 17405874 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
11.42 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Tretinoin |
11.42 | 16594593 16946489 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
3.56 | 20056578 |
MESH:D009421 |
Nervous System Malformations |
|
Tetrachlorodibenzodioxin |
9.15 | 14600291 |
MESH:D009421 |
Nervous System Malformations |
|
Tretinoin |
9.15 | 9125849 |
MESH:D009436 |
Neural Tube Defects |
|
4,4'-diaminodiphenylmethane |
16.74 | 6679447 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
16.74 | 12854658 |
MESH:D009436 |
Neural Tube Defects |
|
Tretinoin |
16.74 | 9142499 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
16.74 | 16359493 8888407 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.36 | 16436463 |
MESH:D009765 |
Obesity |
|
Dietary Fats |
4.34 | 20518802 19632207 16723640 21332399 18457598 18674790 20132043 17217161 11836018 |
MESH:D009765 |
Obesity |
|
pirinixic acid |
4.34 | 20558911 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
8.55 | 16049721 |
MESH:D009784 |
Occupational Diseases |
|
4,4'-diaminodiphenylmethane |
8.55 | 6482804 4026338 |
MESH:D009902 |
Optic Neuritis |
|
4,4'-diaminodiphenylmethane |
4.91 | 3988306 |
MESH:D010003 |
Osteoarthritis |
|
Aspirin |
3.99 | 7009135 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
4.77 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Tretinoin |
4.77 | 16936753 |
MESH:D010146 |
Pain |
|
Aspirin |
6.82 | 6995502 6363464 |
MESH:D010146 |
Pain |
|
Tretinoin |
6.82 | 16870215 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.21 | 19003803 16929163 15113037 16500647 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tretinoin |
5.21 | 15976015 |
MESH:D010212 |
Papilloma |
|
4,4'-diaminodiphenylmethane |
3.38 | 7296757 |
MESH:D010300 |
Parkinson Disease |
|
Atrazine |
3.23 | 17218051 |
MESH:D010382 |
Peliosis Hepatis |
|
Tetrachlorodibenzodioxin |
4.14 | 12520081 |
MESH:D010438 |
Peptic Ulcer Hemorrhage |
|
Aspirin |
5.43 | 11156591 |
MESH:D020795 |
Photophobia |
|
Aspirin |
5.66 | 15240983 |
MESH:D010787 |
Photosensitivity Disorders |
|
4,4'-diaminodiphenylmethane |
4.36 | 6228378 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Tetrachlorodibenzodioxin |
3.45 | 18163543 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Tetrachlorodibenzodioxin |
9.10 | 11896295 11399792 11118676 11222880 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
9.10 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
3.39 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
3.39 | 16039940 |
MESH:D011507 |
Proteinuria |
|
Tretinoin |
3.50 | 16636307 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.44 | 12752131 11422049 |
MESH:D011625 |
Pterygium |
|
Tretinoin |
4.68 | 16723453 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.92 | 18722050 15538739 18286688 16160472 |
MESH:D015427 |
Reperfusion Injury |
|
pirinixic acid |
2.33 | 19058328 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Oxygen |
4.40 | 17627322 18339021 |
MESH:D012135 |
Respiratory Sounds |
|
Atrazine |
4.41 | 11874814 |
MESH:D015619 |
Respiratory System Abnormalities |
|
Tetrachlorodibenzodioxin |
3.73 | 18990726 |
MESH:D012162 |
Retinal Degeneration |
|
4,4'-diaminodiphenylmethane |
3.29 | 3692021 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Tretinoin |
10.51 | 16116481 16283617 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
10.51 | 19155313 |
MESH:D012220 |
Rhinitis |
|
Aspirin |
4.28 | 12372130 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.05 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
5.69 | 18551238 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
5.69 | 15475178 11044598 17978042 14763951 11738929 16876388 3137016 1511512 |
MESH:D012851 |
Sinus Thrombosis, Intracranial |
|
Aspirin |
5.15 | 12269725 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
9.13 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetrachlorodibenzodioxin |
9.13 | 16192470 |
MESH:D012878 |
Skin Neoplasms |
|
Tretinoin |
9.13 | 16467112 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
9.26 | 12854658 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
9.26 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.44 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.48 | 18567086 16424979 16951190 18396642 19015929 17172411 17522103 15786421 19084572 17498489 |
MESH:D013274 |
Stomach Neoplasms |
|
Tretinoin |
2.48 | 17261132 |
MESH:D020521 |
Stroke |
|
Aspirin |
4.29 | 16403987 |
MESH:D013398 |
Sudden Infant Death |
|
Oxygen |
5.43 | 12563064 |
MESH:D013927 |
Thrombosis |
|
Aspirin |
4.42 | 17672075 |
MESH:D013959 |
Thyroid Diseases |
|
Tetrachlorodibenzodioxin |
3.80 | 12697716 |
MESH:D013964 |
Thyroid Neoplasms |
|
4,4'-diaminodiphenylmethane |
6.85 | 1399818 3712494 7505956 6587162 6582329 |
MESH:D013964 |
Thyroid Neoplasms |
|
Tretinoin |
6.85 | 17045167 16026305 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
9.50 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
Tretinoin |
9.50 | 16051514 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.13 | 17262798 |
MESH:D014376 |
Tuberculosis |
|
Tretinoin |
3.16 | 16040207 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.41 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
8.06 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
4,4'-diaminodiphenylmethane |
8.06 | 8074119 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
8.06 | 11723127 16712894 17306315 16452187 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.53 | 8888407 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
4.21 | 10091137 |
MESH:D014581 |
Urticaria |
|
Aspirin |
4.33 | 20485159 10982225 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
15.29 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
15.29 | 11813266 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Tretinoin |
15.29 | 16129372 |
MESH:D014604 |
Uveal Neoplasms |
|
Tretinoin |
4.50 | 16752155 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
4.32 | 17056641 |
MESH:D054079 |
Vascular Malformations |
|
Tetrachlorodibenzodioxin |
4.49 | 12125929 |
MESH:D014820 |
Vitiligo |
|
Tretinoin |
3.95 | 16761959 |
MESH:D019282 |
Wasting Syndrome |
|
Tetrachlorodibenzodioxin |
4.14 | 15886252 |
MESH:D015430 |
Weight Gain |
|
Dietary Fats |
3.64 | 16723640 |
MESH:D009396 |
Wilms Tumor |
|
Tretinoin |
3.87 | 16287080 |